Jove
Visualize
Contact Us

Related Experiment Videos

Diode laser cyclophotocoagulation in refractory glaucoma

M C Linsen1, C Mannes, T Zeyen

  • 1Department of Ophthalmology, Middelheim Hospital, Antwerp, Belgium.

Bulletin De La Societe Belge D'Ophtalmologie
|January 27, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial.

Journal of neuro-oncology·2023
Same author

The effect of phacoemulsification and combined phaco/glaucoma procedures on the intraocular pressure in open-angle glaucoma. A review of the literature.

Bulletin de la Societe belge d'ophtalmologie·2012
Same author

Anterior segment ischemia with rubeosis iridis after a circular buckling operation treated successfully with an intravitreal bevacizumab injection: a case report and review of the literature.

Bulletin de la Societe belge d'ophtalmologie·2012
Same author

Paper retracted from BSBO 316. "What do we know about trachoma in the economically weakest infantile population of Kara in Togo?".

Bulletin de la Societe belge d'ophtalmologie·2011
Same author

Patient-reported outcomes (PRO's) in glaucoma: a systematic review.

Eye (London, England)·2011
Same author

Appraisal of optic disc stereo photos pre- and post-training session.

Bulletin de la Societe belge d'ophtalmologie·2011
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Contact diode cyclophotocoagulation effectively lowers intraocular pressure (IOP) and reduces medication needs in patients with intractable glaucoma. This safe procedure offers a viable treatment option for refractory glaucoma cases.

Area of Science:

  • Ophthalmology
  • Glaucoma Research
  • Surgical Interventions

Background:

  • Intractable glaucoma poses significant challenges to maintaining ocular health.
  • Refractory glaucoma often requires advanced treatment modalities.
  • Contact diode cyclophotocoagulation is an established, though sometimes debated, therapeutic option.

Purpose of the Study:

  • To evaluate the efficacy and safety of contact diode cyclophotocoagulation.
  • To assess the impact of the procedure on intraocular pressure (IOP).
  • To determine changes in the number of glaucoma medications post-treatment.

Main Methods:

  • Retrospective analysis of 19 eyes from 19 patients with intractable glaucoma.
  • Treatment involved contact diode cyclophotocoagulation.

Related Experiment Videos

  • Intraocular pressure (IOP) and medication usage were monitored pre- and post-procedure.

    • Main Results:

    • Mean IOP significantly decreased from 31.7 mmHg to 23.7 mmHg (p=0.02).
    • The average number of glaucoma medications required fell from 1.9 to 1.3 (p=0.03).
    • Mean follow-up duration was 4 months, ranging from 1 to 11 months.

    Conclusions:

    • Contact diode cyclophotocoagulation demonstrates effectiveness in managing refractory glaucoma.
    • The procedure is associated with significant reductions in IOP and medication burden.
    • Diode cyclophotocoagulation appears to be a safe and beneficial option for intractable glaucoma.